
Maze Therapeutics reported that its Phase 2 trial of the genetic kidney disease candidate MZ‑001 achieved its primary efficacy and safety goals, showing a roughly 30% slowdown in eGFR decline versus placebo. The double‑blind study enrolled 150 patients with autosomal dominant polycystic kidney disease and demonstrated a safety profile comparable to standard care. Results position Maze as a direct competitor to Vertex Pharmaceuticals, which is pursuing a similar mechanism in the same disease space. The data also support a planned Phase 3 launch later in 2026.

A University of Toronto study published in JAMA Network Open found that preschoolers who consume high levels of ultra‑processed foods at age three are more likely to exhibit anxiety, aggression, hyperactivity and fearfulness by age five. The analysis of over...

The East Kent Hospitals NHS Trust delayed reporting a suspected meningitis case at Queen Elizabeth the Queen Mother Hospital by two days, breaching the Health Protection Regulations that require immediate notification. The lag slowed contact tracing and public warnings, contributing...
WuXi Biologics reported record 2025 results, with revenue up 16.7% and IFRS gross profit climbing 30.9%, lifting its gross margin to 46%. The growth was driven by expanding research, development and manufacturing contracts and tighter cost control across its global...
Adolescents represent a hidden segment of the tuberculosis epidemic, with roughly 750,000 teens contracting TB worldwide each year and about 20,000 cases in South Africa alone. Because health data split patients into children or adults, teenagers fall between categories, leading...

The €2.2 billion (≈$2.42 billion) national children’s hospital in Ireland has missed its 18th deadline, with contractor Bam confirming it will not achieve substantial completion by 30 April 2026. The National Paediatric Hospital Development Board (NPHDB) has invoked contract rights, including withholding 15% of...

Sarah London has become the youngest-ever female CEO of a Fortune 500 company, taking the helm of Centene, the nation’s largest Medicaid insurer. She is steering the firm through steep federal Medicaid cuts and rising health‑care costs by trimming non‑core...

Novo Nordisk and United Laboratories reported Phase‑II data for the GLP‑1 agonist UBT251 in 211 Chinese patients with type‑2 diabetes. Over 24 weeks, UBT251 achieved a 2.16 % HbA1c reduction, outperforming semaglutide’s 1.77 % and placebo’s 0.66 % from a baseline of 8.12 %....

Gilead announced a $2.1 billion acquisition of Ouro Medicines and its T‑cell engager OM336, planning to split the deal with long‑time partner Galapagos. Johnson & Johnson and Protagonist Therapeutics secured FDA approval for Icotyde, an IL‑23 receptor blocker that becomes Protagonist’s...

A genomic survey of over 18,000 *Escherichia coli* genomes has mapped 90 capsular K‑loci, revealing that five capsule types (K1, K5, K52, K2, K14) cause more than half of bloodstream and urinary‑tract infections in Europe. The study links these high‑risk...

Researchers at Australia’s Peter Doherty Institute have created a portable, CRISPR‑based diagnostic that simultaneously detects syphilis, HSV, chlamydia and gonorrhea in under an hour. The assay also identifies a key antibiotic‑resistance gene in gonorrhea, delivering 97‑100% accuracy compared with laboratory...

Merck (MSD) has entered a multi‑year research partnership with Quotient Therapeutics to uncover new drug targets for inflammatory bowel disease using Quotient’s somatic genomics platform. The deal provides Quotient with $20 million upfront and up to $2.2 billion in regulatory, development and...

A recent BBC and New Statesman investigation uncovered preventable infant deaths at University Hospitals Sussex NHS Foundation Trust, highlighting a deepening maternal‑health crisis in the United Kingdom. Over the past 15 years, maternal mortality rates have risen steadily, exposing gaps in NHS...

Musculoskeletal (MSK) conditions remain the top driver of disability claims in the U.S., costing employers billions in lost productivity and medical expenses. The article argues that most of this spend is preventable through early, accessible care rather than reactive, high‑cost...

In 2024 more than 2.3 million Americans chose dental veneers, a 40% surge from five years earlier. Veneers combine cosmetic transformation with a protective seal that can preserve enamel and stave off costly restorative work such as crowns, which typically cost...
Royal Philips has launched IntraSight Plus, an FDA‑cleared and CE‑marked interventional cardiology platform that unifies intravascular ultrasound, iFR/FFR physiology, and angiographic imaging on a single screen. The system promises up to 47% reduction in procedure time by streamlining data entry...

The Milan Longevity Summit 2026, held May 20‑23 at Allianz MiCo, convenes leaders across finance, AI, agri‑food, urban design and more to re‑engineer systems for an aging world. Using the One Health framework, the event treats human longevity as intertwined...

Pixee Medical has secured a European CE mark for its Knee+ NexSight augmented‑reality platform, enabling the first EU total knee arthroplasty procedures using the technology. The system projects a voice‑controlled virtual overlay during surgery, delivering robotic‑level precision without a robot,...

Ventura Securities has initiated coverage on Park Medi World Ltd (PMWL) with a Buy rating and a $3.4 target price, suggesting roughly 38% upside over the next two years. The hospital chain, listed at $2.0 per share, leverages a capital‑efficient...

Ionis Pharmaceuticals received FDA acceptance of its new drug application for zilganersen and a priority‑review designation for treating Alexander disease, with a PDUFA target action date of September 22, 2026. The Phase III trial enrolled 54 patients aged 1.5 to 53...

French imaging contrast agent maker Guerbet is confronting a severe FDA warning after inspectors found significant good manufacturing practice violations at its Raleigh, North Carolina plant. The citation has already depressed Americas revenue by 4% year‑over‑year and reduced MRI‑related sales,...

Harish Rana, a 31‑year‑old Indian man who had been in a coma since a 2013 balcony fall, died at AIIMS after the Supreme Court authorized the removal of his life‑support machines. The decision marks India’s first court‑approved instance of passive...

A Los Angeles woman, Sophia Shaklian, was sentenced to 35 months in federal prison for orchestrating a Medicare fraud scheme that siphoned more than $14 million through fake diagnostic imaging and hospice services. She owned multiple sham providers and submitted fraudulent...

The Irish Dental Council disclosed that an unregistered dentist was providing X‑ray treatments from the sitting‑room of a Dublin apartment, exposing a loophole in the Dentists Act 1985 that prevents regulation of non‑licensed practices. The council reported it could not act...

The Lancet Commission proposes a citizen‑centred health system for India, outlining six reform actions. It argues that despite adequate per‑capita funding of roughly $24 in many states, the public sector fails to deliver universal health coverage because budgets are fragmented,...

Georgia’s "Pathways to Coverage" Medicaid reform, launched in July 2023, aimed to expand coverage for low‑income workers but enrolled only 8,077 of the 240,000 eligible. The program’s private‑contractor‑run IT platform, built by Deloitte for $528 million, generated frequent form changes and...

Home‑based care providers are under intense reimbursement pressure, inflation and staffing shortages, prompting a sharp focus on efficiency. Well Care Health, a 700‑employee provider serving 5,000 daily patients across North and South Carolina, warns that cost‑cutting initiatives, especially AI‑driven ones,...
Researchers at Trinity College Dublin have demonstrated that a single dose of interferon‑gamma can “train” human macrophages to more effectively kill drug‑resistant bacteria such as MRSA and Mycobacterium tuberculosis. The IFN‑γ‑trained cells undergo epigenetic reprogramming, rely on glutamine metabolism, and...

Cornell researchers have unveiled the microscale optoelectronic tetherless electrode (MOTE), a neural implant barely larger than a grain of salt. The 300 µm‑by‑70 µm device wirelessly transmits brain‑wave data via infrared light and has demonstrated chronic operation in awake mice for more...
Researchers at the University of Illinois Chicago have repurposed the FDA‑approved cancer drug doxorubicin to combat drug‑resistant herpes simplex virus type 1 (HSV‑1). Using their AI‑driven platform HerpDock, they identified doxorubicin’s ability to block the PI3K‑AKT‑mTOR pathway that the virus exploits,...

Maternal mortality in the United States reached 649 deaths in 2024, a slight decline from 669 in 2023 but still far above historical norms. The surge is driven by two intertwined crises: 2.2 million women of child‑bearing age live in maternity‑care...
CMS announced the Accelerating State Pediatric Innovation Readiness and Effectiveness (ASPIRE) Model, a ten‑year voluntary initiative for up to five states to improve whole‑person care for Medicaid and CHIP beneficiaries up to age 21. The model places accountability for quality...

The article outlines BioCentury’s cookie policy, detailing the categories of cookies used on its website—strictly necessary, functional, marketing, advertising, and analytics. Each type is described in terms of purpose, activation status, and impact on user experience. The policy emphasizes that...

Wayne General Hospital in rural Mississippi has adopted Eko Health’s AI‑powered digital stethoscope, allowing clinicians to detect cardiac conditions such as atrial fibrillation, low ejection fraction and valvular disease in real time. The AI engine combines auscultation with ECG data...

AHIP President and CEO Mike Tuffin told a Washington briefing that affordability is the organization’s top priority as hospital, drug and specialty care costs outpace wages and inflation. He blamed hospital consolidation and drug‑maker patent thickets for rising premiums and...

Sexual Health Victoria (SHV) has launched the statewide "Unusual Discharge?" campaign to confront a sharp rise in sexually transmissible infections. Gonorrhoea cases have jumped 52% and chlamydia exceeds 22,000 diagnoses in the past year, while only 16% of Australians have...

AbbVie has secured a multi‑year deal to become Major League Baseball’s Official Pharmaceutical Partner beginning with the 2026 season, extending its Striking Out Cancer initiative league‑wide. The program will donate $20 for every strikeout, up to $1 million per season, with...

Amplitude has introduced its Global Agent AI, an analytics assistant that operates on the same governed data healthcare teams already use. The AI analyzes events, funnels, and cohorts, delivering natural‑language insights while respecting existing role‑based access controls and avoiding exposure...

Intelligent and miniaturized drug delivery devices (IMDDDs) combine biotechnology, AI, electronics, and novel materials to provide precise, programmable drug release inside the body. These platforms integrate real-time sensing with adaptive control, enabling dose adjustments based on biomarkers such as glucose...

New Lancet Public Health research models a 20% tax on unhealthy foods in Australia. The model predicts 212,000 premature deaths avoided and about A$14.9 bn (≈ $9.8 bn USD) saved in health‑care costs. If the tax revenue funds fruit and vegetable subsidies, prices could...

Social media influencers are promoting full‑body MRI scans, AMH fertility tests, and testosterone panels, prompting a surge in consumer demand for these pricey examinations. Medical authorities warn that these tests often detect incidental findings or provide misleading information, leading to...
The Federal Trade Commission and CVS Caremark have reached a settlement that resolves all claims alleging the pharmacy‑benefit manager inflated insulin prices through anticompetitive rebate practices. Court filings on March 23 indicate the agreement ends the FTC’s lawsuit in its...

New Zealand has unveiled a National Diabetes Roadmap that uses smart technologies and digital health tools to overhaul prevention, diagnosis, and management of diabetes. The plan addresses an estimated 348,000 New Zealanders with diabetes, especially high‑risk Māori, Pacific and South Asian groups,...

Dr. Robert Malone, appointed vice‑chair of the Advisory Committee on Immunization Practices (ACIP) by Health Secretary Robert F. Kennedy Jr., resigned abruptly after a federal judge ruled the panel’s advisers lacked the expertise to issue vaccine guidance. The court order placed ACIP in...
A recent Rock Health survey of 8,000 U.S. adults shows that one in three consumers have turned to AI chatbots for health information, a usage rate that has doubled over the past year. ChatGPT dominates the market with a 23%...
Artesia General Hospital in rural New Mexico has integrated Microsoft’s Dragon Copilot AI scribe into its TruBridge electronic health record. Physicians report noticeably faster clinical documentation compared with legacy dictation tools, freeing up time for patient interaction. The hospital cites...

A two‑year longitudinal MRI study of 62 bipolar disorder patients and 62 healthy controls tracked gray matter volume in the right exterior cerebellum. Patients who did not experience new manic or depressive episodes showed significant cerebellar volume loss, while those...

A New York private‑equity firm bought a 181‑bed skilled nursing facility in South Carolina, planning to lease it to a regional operator. A New Jersey‑based operator acquired a 120‑bed Florida facility and a 100‑bed Mississippi property, both with high occupancy...

Telehealth has become essential for rural nursing homes, a fact underscored by the recent government shutdown that exposed reliance on temporary waivers. Operators like Care Initiatives use virtual platforms for psychiatry, therapy, and after‑hours care, while advocacy groups push the...
The Canadian Union of Public Employees’ Lead Table for long‑term care workers in Nova Scotia announced a bargaining impasse after the provincial government presented the same contract proposal for the fifth time. Union leaders called the offer unfair and said...